Lightfective

What Lightfective does

Lightfective Ltd. is an Israel-based medical device company founded in 2017 that develops and commercializes the ReBorn system, a professional non-invasive fat reduction device. The technology centers on a patented Power LED array operating at 940nm infrared wavelength, with four lightweight applicators each containing 63 medical-grade LEDs arranged in a 9x7 matrix. The applicators deliver uniform, homogeneous heat at 43-47°C across a 70x50mm spot size with an 80-degree optical angle — claimed to be the largest effective spot size in the industry and 1.45x larger than competing diode-laser systems. A proprietary contact cooling system maintains patient safety and comfort during 35-minute treatment sessions with no downtime. Unlike diode-laser competitors, the LED-based architecture eliminates the up to 60% center-to-periphery heat disparity that has historically limited treatment consistency.

The company serves medical-aesthetic practitioners — including dermatologists, plastic surgeons, aesthetic physicians, and maxillofacial surgeons — who perform body contouring and localized fat reduction procedures in clinical settings. ReBorn is the company's sole commercial product and the first in a planned line of professional solutions, with no consumables, disposables, or per-treatment costs built into the model. Revenue is generated primarily through one-time hardware sales of the ReBorn device, supplemented by ongoing technical service and support over the device lifecycle.

Lightfective distributes globally through a partner and distributor network, with active agreements in at least seven countries: Japan, France, Italy, Belgium, Mexico, Thailand, and Ireland, with additional prospects in Latin America. The company uses a multi-channel go-to-market approach combining international aesthetics conference presence (IMCAS Paris, IMCAS Asia Bangkok, AMWC Monaco), a KOL lecture and endorsement program, partner co-marketing via a dedicated Distributor Center portal, and educational content marketing. The company has received Thai FDA approval (July 2023) and an Honourable Mention in the 2022 European Product Design Awards, and is led by a founder team with a documented track record of medical-aesthetics exits exceeding $2B in aggregate.

Name

Lightfective

Legal name

Lightfective Ltd

Website

https://lightfective.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

1–10 employees

Short description

Lightfective is an Israeli medical device company that manufactures the ReBorn system, a non-invasive fat reduction device using patented 940nm Power LED technology. It sells the hardware directly and through international distributors to dermatologists, plastic surgeons, and aesthetic practitioners across multiple countries.

Ownership category

akta.pro rank

Product category

Aesthetic Medical Equipment / Body Contouring Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Energy-Based Surgical Devices (Electrosurgery, RF, Ultrasonic, Laser) (HLAHADAC)

akta.pro secondary industry

Laser & Energy-Based Dermatology (HLAKACAF)

Keywords

• Non-invasive fat reduction
• Aesthetic medical devices
• Body contouring equipment
• LED lipolysis technology
• Professional fat reduction

Headquarters

HQ city

Caesarea

HQ country

Israel

HQ region

Middle East

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Operations, Marketing or Sales, Personnel, Supply Chain

Revenue model

1. ReBorn Device Sales: Sale of the ReBorn non-invasive fat reduction device to medical-aesthetic practitioners and clinics. Device requires no consumables or per-treatment costs, representing a one-time hardware sale with ongoing support services.
2. Technical Service and Support: Ongoing technical service, maintenance, and support provided throughout device lifecycle as part of partnership commitment.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Core offering

Lightfective manufactures and sells the ReBorn device, a professional non-invasive fat reduction system for medical-aesthetic practitioners and clinics. The device uses patented Power LED technology operating at 940nm infrared wavelength to deliver uniform, homogeneous heat (43-47°C) across the treatment area, inducing fat cell apoptosis for circumference reduction. It includes four lightweight applicators with integrated contact cooling, requires no consumables or per-treatment costs, and delivers 35-minute hands-free treatments.

Product overview

Lightfective offers a single unified product—the ReBorn device—for professional non-invasive fat reduction. The ReBorn system is the company's flagship and first in a planned line of professional solutions. It leverages proprietary Power LED technology to deliver consistent, homogeneous heat optimized for fat reduction treatments. The device is designed for medical-aesthetic practitioners and features 4 lightweight ergonomic treatment applicators, each containing 63 Power LEDs at 940nm IR range. The system requires no consumables and offers consistent clinical outcomes with no downtime for patients.

Differentiator

Problem solved

Functional benefit

Brands

• ReBorn: Non-invasive fat reduction device using patented Power LED technology for professional body contouring treatments.

Products and services

• ReBorn

Named customers3 records

Segments2 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Seven partnerships are on record, tiered core and secondary.

• AMPEX (Thailand)coreChannel Partner/ Reseller/ Distributor · 2 July 2023Partnership with AMPEX for Thailand market distribution following Thai FDA approval. Thailand represents an emerging market with great receptiveness to innovative tech solutions. AMPEX will help distribute ReBorn device and empower individuals through the technology.
• Japan Distribution PartnerscoreChannel Partner/ Reseller/ DistributorDistribution agreement signed following IMCAS Paris 2022. Japan represents an important market for aesthetic technology adoption.
• France Distribution PartnerscoreChannel Partner/ Reseller/ DistributorDistribution agreements established in France. Key opinion leaders like Dr. Jean Michel Mazer actively promoting ReBorn technology in French market.
• Italy Distribution PartnerscoreChannel Partner/ Reseller/ DistributorDistribution agreements signed with Italian partners following IMCAS events. Dr. Carlo Borriello serves as Key Opinion Leader using ReBorn in Italian practice.
• Belgium Distribution PartnerssecondaryChannel Partner/ Reseller/ DistributorDistribution agreements established in Belgium following IMCAS Paris 2022.
• Mexico Distribution PartnerssecondaryChannel Partner/ Reseller/ DistributorDistribution agreements signed with partners in Mexico for Latin American market expansion.
• Ireland Distribution PartnerssecondaryChannel Partner/ Reseller/ DistributorNew distribution activities in Ireland following strong IMCAS 2022 performance.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Alma Lasers: Alma Lasers (a division of Sisram Medical) sells Accent Prime and other energy-based body-contouring systems that compete with ReBorn. Lightfective's VP R&D previously worked at Alma, underscoring the close talent and product overlap.
• Solta Medical (Bausch Health): Solta markets Thermage, Liposonix, and Clear+Brilliant — broad energy-based aesthetic systems including the Liposonix high-intensity focused ultrasound fat reduction platform, a competing non-invasive modality.
• Allergan Aesthetics (AbbVie): Owner of CoolSculpting, the legacy market leader in non-invasive cryolipolysis fat reduction. A broad incumbent in medical aesthetics with deep clinical evidence and global sales force that competes for the same clinic budgets as ReBorn.
• Lumenis (Boston Scientific): Lumenis, recently acquired by Boston Scientific, sells the NuEra tight and other RF-based body-contouring devices. As a broad incumbent in energy-based aesthetics, it competes for the same clinic capital expenditure budgets.

Direct peers

• BTL Industries: BTL makes EmSculpt, EmSculpt Neo, and EmTone, the dominant non-invasive body contouring and muscle-building platforms. It competes head-to-head with ReBorn in medical-aesthetic clinics worldwide.
• Cynosure: Cynosure's SculpSure is a 1060nm diode-laser non-invasive lipolysis device and one of ReBorn's closest technology analogues, marketed to the same dermatology and plastic-surgery channel.
• Cutera: Cutera sells truSculpt iD and truSculpt flex, RF-based body contouring and muscle-sculpting systems that directly compete with ReBorn in medical-aesthetic practices globally.
• Venus Concept: Venus Concept markets Venus Bliss ( diode laser + RF for fat reduction) and broader aesthetic platforms, directly competing with ReBorn in the same medical-aesthetic channel. Notably, Lightfective's chairman previously founded Venus Concept.
• InMode: InMode's BodyTite, Evolve, and Evoke platforms use RF-based energy for body contouring and skin tightening, positioning InMode as a direct competitor in physician-dispatched non-invasive body shaping.

Emerging players

• Sciton: Sciton offers BBL Hero and the Profound platform for body contouring and skin remodeling, and increasingly targets the same medical-aesthetic clinics as ReBorn with energy-based treatments.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/Lightfective
• LinkedInlinkedin.com/company/lightfective

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lightfective